Saba Capital Amends Filing for Nuveen NJ Muni Fund

TL;DR

Saba Capital updated its 13D filing for Nuveen NJ Muni Fund. Watch for potential shifts.

AI Summary

Saba Capital Management, L.P. filed an amendment (11) to its Schedule 13D on October 30, 2024, regarding Nuveen New Jersey Quality Municipal Income Fund. Saba Capital Management GP, LLC and Boaz R. Weinstein are listed as group members. The filing concerns common shares of the fund.

Why It Matters

This amendment indicates ongoing activity or changes in Saba Capital's stake or intentions regarding the Nuveen New Jersey Quality Municipal Income Fund, which could influence the fund's market dynamics.

Risk Assessment

Risk Level: medium — Schedule 13D filings often signal activist investor intent or significant stake changes, which can lead to volatility.

Key Players & Entities

• Saba Capital Management, L.P. (company) — Filing entity
• Nuveen New Jersey Quality Municipal Income Fund (company) — Subject company
• Saba Capital Management GP, LLC (company) — Group member
• Boaz R. Weinstein (person) — Group member
• Michael D'Angelo (person) — Contact person

FAQ

Key Financial Figures

• $0.01 — FUND (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securiti
• $67,086,530 — ported herein. A total of approximately $67,086,530 was paid to acquire the Common Shares r

Filing Documents

• formsc13da.htm (SC 13D/A) — 57KB
• 0001062993-24-018130.txt ( ) — 59KB

is hereby amended and supplemented as follows

Item 4 is hereby amended and supplemented as follows: On October 30, 2024, Saba Capital Master Fund, Ltd., a private fund advised by Saba Capital, formally withdrew its notice of intent to nominate the Nominee as an independent trustee for election at the Issuer's 2024 annual meeting of shareholders. Item 5. INTEREST IN SECURITIES OF THE ISSUER (a) See rows (11) and (13) of the cover pages to this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 41,232,935 shares of common stock outstanding as of 2/29/24, as disclosed in the company's N-CSR filed 5/3/24 (b) See rows (7) through (10) of the cover pages to this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. CUSIP No. 67069Y102 SCHEDULE 13D/A Page 6 of 8 Pages (c) The transactions in the Common Shares effected within the past sixty days by the Reporting Persons, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. (d) The funds and accounts advised by Saba Capital have the right to receive the dividends from and proceeds of sales from the Common Shares. (e) Not applicable. CUSIP No. 67069Y102 SCHEDULE 13D/A Page 7 of 8 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: October 30, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 67069Y102 SCHEDULE 13D/A Page 8 of 8 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 10/25/2024 Sell 39,244 12.62 10/28/2024 Sell 5,400 12.54 10/29/2024 Sell 19,153 12.40

View Full Filing

View this SC 13D/A filing on SEC EDGAR